AZTR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: N/A

Insider Buying (Last 12 Months): $3,115,476.00

Insider Selling (Last 12 Months): $0.00

Azitra Insider Trading History Chart

Azitra Share Price & Price History

^$0.22

+0.30 (1.20%)

As of 04/26/2024 01:00 AM ET

Days: 30 | 90 | 365

He Is Giving Away Bitcoin

From Crypto Swap Profits | Ad

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

Azitra Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/29/2024	Norm Staskey	CFO	Buy	47,600	$0.21	$9,996.00	51,100
2/13/2024	Francisco D Salva	CEO	Buy	333,300	$0.30	$99,990.00	338,300
2/13/2024	Norm Staskey	CFO	Buy	3,300	$0.30	$990.00	3,500
2/13/2024	Travis Whitfill	COO	Buy	15,000	$0.30	$4,500.00	334,500
6/21/2023	Leslie W Kreis	Major Shareholder	Buy	600,000	$5.00	$3,000,000.00	1,747,670

Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years

From Banyan Hill Publishing | Ad

If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)

Watch my video for all of the details

SEC Filings (Institutional Ownership Changes) for Azitra (NYSEAMERICAN:AZTR)

11.16% of Azitra stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Azitra Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company	Details
11/14/2023	Knollwood Investment Advisory LLC	41,537	$62K	0.0%	N/A	0.343%
11/13/2023	Warberg Asset Management LLC	35,000	$52K	0.0%	+20.7%	0.289%

Data available starting January 2016

Azitra, Inc., an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease. The company also develops ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. It has a collaboration with Bayer. The company was incorporated in 2014 and is based in Branford, Connecticut.

Today's Range

Now: $0.22

$0.21

$0.23

50 Day Range

MA: N/A

52 Week Range

Now: $0.22

$0.16

$5.18

Volume

429,042 shs

Average Volume

757,453 shs

Market Capitalization

$6.29 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Azitra?: Azitra's top insider investors include:
Leslie W Kreis (Major Shareholder)
Francisco D Salva (CEO)
Travis Whitfill (COO)
Norm Staskey (CFO)
Learn More about top insider investors at Azitra.